R. Yates

发表

Blood–Brain Barrier Penetration of Zolmitriptan—Modelling of Positron Emission Tomography Data

M. Bergström, A. Wall, B. Långström, 2006, Journal of Pharmacokinetics and Pharmacodynamics.

Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel®) in patients with schizophrenia

M. Bergström, B. Långström, L. Lindström, 1998, Psychopharmacology.

Effects of the aromatase inhibitor anastrozole on serum oestrogens in Japanese and Caucasian women

M. Dowsett, R. Yates, M. Tsuboi, 2000, Cancer Chemotherapy and Pharmacology.

Arimidex (ZD1033): a selective, potent inhibitor of aromatase in postmenopausal female volunteers.

M. Dowsett, A. Selen, P. Wyld, 1996, British Journal of Cancer.

ARIMIDEX™: A new oral, once-a-day aromatase inhibitor

M. Dowsett, A. Webster, L. Demers, 1995, The Journal of Steroid Biochemistry and Molecular Biology.

Pharmacokinetics and Tolerability of the Orally Active Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 in Healthy Volunteers

C. Morris, H. Swaisland, A. Dane, 2001, Clinical pharmacokinetics.

Time course for dopamine and serotonin receptor occupancy in the brain of schizophrenic patients following dosing with 150 MG ‘seroquel’ TID

B. Långstrom, O. Gefvert, T. Lundberg, 1996, Schizophrenia Research.

The effect of optic stalk section on the amino acid content of rat retina

R. Yates, P. Keen, 1975, Brain Research.

Pharmacokinetics of cefotetan in patients with end-stage renal failure on maintenance dialysis.

D. Reeves, R. Yates, L. White, 1986, The Journal of antimicrobial chemotherapy.

Metabolism and enantioselective pharmacokinetics of Casodex in man.

R. Yates, D. C. Jones, I. Cockshott, 1993, Xenobiotica; the fate of foreign compounds in biological systems.

A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 minutes

M. Hutchison, R. Yates, S. Freestone, 1997, European Journal of Drug Metabolism and Pharmacokinetics.

O-12-9 Time course for dopamine and serotonin receptor occupancy in the brain of schizophrenic patients following dosing with 150 mg ‘seroquel’ TID

B. Långstrom, O. Gefvert, T. Lundberg, 1996, European Neuropsychopharmacology.

Effects of the Antimigraine Compound Zolmitriptan (‘Zomig’) on Psychomotor Performance Alone and in Combination with Diazepam in Healthy Volunteers

J. Kemp, A. Hughes, R. Yates, 1998, Cephalalgia : an international journal of headache.

Sign of Leser-Trélat.

R. Yates, D. L. Ellis, 1990, Clinics in dermatology.

Zolmitriptan Intranasal: A Review of the Pharmacokinetics and Clinical Efficacy

P. Goadsby, R. Yates, 2006, Headache.

Pharmacokinetics of Two Multiple-Dosing Regimens of D0870 in Human Immunodeficiency Virus-Positive Patients: a Phase I Study

S. De Wit, J. Edwards, R. Smith, 1998, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics and tolerance of single intramuscular doses of cefotetan in normal Caucasian volunteers.

R. Yates, H. Adam, I. Cockshott, 1983, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of two multiple dosing regimens of D0870 in HIV positive patients: a phase I study

N. Clumeck, R. Yates, S. Wit, 1995 .

Glutamic acid, GABA and their metabolising enzymes in the frog central nervous system

R. Yates, P. Taberner, 1975, Brain Research.

The pharmacokinetics of cefotetan excretion in the unobstructed biliary tree.

R. Yates, A. Owen, J. Manson, 1983, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and tolerance of a 24-h infusion of cefotetan disodium (with and without loading dose) in normal Caucasian volunteers.

R. Yates, H. Adam, R. Donnelly, 1983, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and tolerance of single intravenous doses of cefotetan disodium in male Caucasian volunteers.

E. Laws, R. Yates, H. Adam, 1983, The Journal of antimicrobial chemotherapy.

Tectal deafferentation in the frog: Selective loss of l-glutamate and γ-aminobutyrate

P. Roberts, R. Yates, 1976, Neuroscience.

Preliminary Studies of the Pharmacokinetics and Tolerability of Zolmitriptan Nasal Spray in Healthy Volunteers

E. Seaber, R. Yates, R. Dixon, 2002, Journal of clinical pharmacology.

Distribution of Intranasal 11C-Zolmitriptan assessed by Positron Emission Tomography

M. Bergström, G. Antoni, B. Långström, 2005 .

True nasopharyngeal absorption of zolmitriptan after administration via nasal spray in healthy male volunteers

M. Kågedal, R. Yates, P. Zingmark, 2005 .

Distribution of intranasal C-zolmitriptan assessed by positron emission tomography.

M. Bergström, G. Antoni, B. Långström, 2005, Cephalalgia : an international journal of headache.

Proceedings: Distribution of amino acids in subdivided rat retinae.

R. Yates, P. Keen, 1974, British journal of pharmacology.

Assessment of Pharmacokinetic Interaction Potential Between Caffeine and Methylliberine

M. Butawan, R. Bloomer, R. Yates, 2021, medRxiv.

The Metabolism of Zolmitriptan

J. Kemp, R. Yates, S. French, 1998, Clinical drug investigation.

A phase I trial to assess the pharmacology of the new oestrogen receptor antagonist fulvestrant on the endometrium in healthy postmenopausal volunteers

R. Yates, R A Yates, S Addo, 2002, British Journal of Cancer.

Distribution of Zolmitriptan into the CNS in Healthy Volunteers

M. Bergström, A. Wall, G. Antoni, 2005, Drugs in R&D.

Zolmitriptan nasal spray: advances in migraine treatment

R. Yates, N. Syrett, S. Abu-Shakra, 2003, Neurology.